https://www.selleckchem.com/pr....oducts/ly3023414.htm
drug concentration monitoring should be executed in the early phase post-ERCP, especially in patients with related factors.Oral administration of resveratrol is able to ameliorate the progression of diabetic nephropathy (DN); however, its mechanisms of action remain unclear. Recent evidence suggested that the gut microbiota is involved in the metabolism therapeutics. In the current study, we sought to determine whether the anti-DN effects of resveratrol are mediated through modulation of the gut microbiota using the genetic db/db mous
Like
Comment
Share
